Figure 7.
CircGPC3 regulates HCC growth and metastasis by sponging miR-578. (A) Venn diagrams showing overlapping miRNAs that bind to circGPC3 identified by circBank and circInteractome. (B) CircGPC3 biotin-labeled probes could capture more circGPC3. (C, D) In the RNA pull-down assay, qRT‒PCR analysis was performed on PLC/PRF/5 and Hep3B2.1-7 cells to predict circGPC3-target miRNAs. (D) Schematic illustration of the binding sites of circGPC3 and miR-578. (E–G) Relative luciferase activities were calculated in PLC/PRF/5 and Hep3B2.1-7 cells cotransfected with miR-578 mimics or mimic-NC and circGPC3-WT or circGPC3-MUT vectors. (H) FISH assay was used to observe the subcellular localization of circGPC3 (red) and miR-578 (green). (I) qRT‒PCR was performed to evaluate the expression of miR-578 in HCC and adjacent normal tissues. (J, K) Transwell assays were used to evaluate the migratory and invasive capabilities of PLC/PRF/5 and Hep3B2.1-7 cells by transfecting these cells with miR-578 mimics or inhibitors. (L, M) Relative migration and invasion rates of PLC/PRF/5 and Hep3B2.1-7 cells were calculated for cells transfected with miR-578 mimics or inhibitors. (N) EdU assays were used to evaluate the proliferative capacities of PLC/PRF/5 cells after transfection with miR-578 mimics or inhibitors. **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant.